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The pandemic that is shocking our lives will also have
an enduring impact on global research priorities [1–3].
It will not be a question of scotomizing important areas
of medicine, but a return to its origins. The extreme
fragmentation of the healthcare offers to citizens
changes its priorities, and bringing together apparently
distant disciplines [4]. The powerful investments that all
nations are making by transforming their hospitals will
not and must not be nullified but converted into large
multidisciplinary departments.
In this new scenario, how will clinical and basic head-
ache research be positioned? Will it have the same ac-
cess to funds, or will global priorities decrease their
force of impact, putting them at least on standby?
PubMed reports for the year 2020 729 papers pub-
lished with “migraine” search, while with “CoViD-19” or
“coronavirus” we can see 3746 items [5]. It is clear from
now that in the next 2–3 years basic, clinical and epi-
demiological research on this pandemic will absorb most
of the publications. Headache area will be strongly pe-
nalized, politically perceived as not a priority, previously
enriched by the use of monoclonal antibodies, and not
lastly for an exquisite, ethical reason.
How is the headache community going to renew itself,
hooking this terrible situation? [6] To give a definite an-
swer today is premature, but surely this pandemic will
change over time the epidemiological expression of
chronic non-communicable diseases. In the next 10 years
we will see growing many pathologies unveiled or trig-
gered by the immunological interactions of SARS-CoV-2
infection [7].
Therefore, epidemiological studies on CoViD-19 clin-
ical interactions, on environmental factors, and not only
on the headache symptom which sums up to 14% of
CoViD-19 patients’ clinical presentations, will have to
inspire the finding of still hidden avenues of research, or
their ex novo creation.
Lastly, the huge economic crisis coming ahead will im-
pact also on availability of funds, prioritized to the
CoViD-19 area, and surely migraine won’t be top ranked
in this list of priorities anymore. Which young re-
searcher, now that hospitals are hiring all the youngsters
in the CoViD-19 areas, will have scientific interest in mi-
graine? This will depend from the vitality and creativity
of our scientific community.
After the pandemic the scientific priorities will see a
revolution, and this will also bring positive notes. We
will see a post-crisis Marshall Plan, and it will be up to
us to be part of it.
The signs of discontinuity, with the swirling chasing
each other marking future appointments through the
“see you at”, are clear and will remain so. No congress
or meeting of medium or large size upwards will be
classed as an acceptable and accepted risk. In an already
digital era, Scientific Societies found themselves unpre-
pared for remotely cultural exchanges, being anchored
to a twentieth-century concept of solving problems with
a handshake, or cementing ideas during the coffee
breaks. The immense economic resources previously al-
located to oceanic meetings, fleets of airplanes to bring
together scientists, will no longer exist at least for a few
years, perhaps forever. And this will mitigate the enor-
mous conflicts of interest that undermined their cred-
ibility and therefore their reason for being.
From now on, the sharing and the scientific debate will
use our digitalized desks, with the predictable reluctance
of some related to habits or the fact that digital sharing
prefers and rewards active participants and not mere
audience. Young researchers, the sherpa of scientific re-
search, will adapt themselves in a Darwinian way to this
evolutive phase [8]. The true congresses of the future
will harbour in scientific journals that will have to offer
not only the aseptic list of papers already undergone the
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rigorous scrutiny of referees, but the critical re-reading
and vulgarization of the messages contained through
blogs, dedicated webinars, audio-podcasts, discussion
forums, Q&A interviews, hybrid or scientific/educational
platforms or new models of augmented reality inter-
action [9]. Is it just not the digital translation of what
already took place in any conference room?
If all of us have reconverted our academic teaching
from frontal to online in a flash, if we made operational
methods of university exams and degrees online, then
we are ready to move from the playful and social use of
technology to a digital revolution where the sharing of
research and the provision of training will find its terri-
tory, in emergency for now, stable immediately after-
wards [10].
It is time to discover new avenues of research and
education.
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